tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market

Clal Biotech (CBI) Income Statement

Compare
0 Followers

Clal Biotech Income Statement

Last quarter (Q2 2025), Clal Biotech's total revenue was ₪0.00, a decrease of ― from the same quarter last year. In Q2, Clal Biotech's net income was ₪-5.17M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
₪ 433.00K₪ 104.00K₪ 370.00K₪ 224.00K₪ 206.00K
Gross Profit
₪ -183.00K₪ 104.00K₪ 370.00K₪ 224.00K₪ 206.00K
Operating Expenses
₪ 6.34M₪ 10.29M₪ 12.27M₪ 77.47M₪ 10.30M
Depreciation and Amortization
₪ 283.00K₪ 526.00K₪ 17.64M₪ 22.51M₪ 23.87M
EBITDA
₪ -6.34M₪ -24.02M₪ 64.22M₪ -55.08M₪ 13.23M
Operating Income
₪ -6.34M₪ -10.18M₪ -27.42M₪ -77.59M₪ 40.15M
Other Income/Expenses
₪ -68.73M₪ -17.91M₪ -13.61M₪ 11.00M₪ 9.68M
Pretax Income
₪ -75.07M₪ -28.09M₪ -41.02M₪ -66.59M₪ 49.84M
Net Income
₪ -62.46M₪ -31.05M₪ -61.74M₪ -89.58M₪ 109.03M
Per Share Metrics
Basic EPS
₪ -0.40₪ -0.20₪ -0.39₪ -0.57₪ 0.68
Diluted EPS
₪ -0.40₪ -0.20₪ -0.39₪ -0.57₪ 0.68
Weighted Average Shares Outstanding
158.44M 156.85M 156.85M 158.44M 161.24M
Weighted Average Shares Outstanding (Diluted)
158.44M 156.85M 156.85M 158.44M 161.24M
Currency in ILS

Clal Biotech Earnings and Revenue History